This silence by Generex / NGIO is literally deafen
Post# of 36537
Yes, it’s year end, but come on. Everyone has been putting out news that actually means something and we are not hearing anything that really has shown true value to be seen.
This 10Q better have something or Joe has been a huge disappointment for the entire year and honestly it’s time for a change. Deals should have pushed us higher, we should have had news on the peptides.
So, this 10Q should be positive. If it is not, it’s time to look at Joe again. Two years in a row with same results is totally unacceptable.